Effect of percutaneous tactics of complete and incomplete myocardial revascularization in acute coronary syndrome with ST-segment elevation on the dynamics of laboratory and instrumental parameters during the hospital treatment period

Main Article Content

S. O. Chaichuk
M. Yu. Sokolov
M. М. Dolzhenko

Abstract

The aim – to identify and study the effect of percutaneous tactics of complete and incomplete myocardial revascularization on the dynamics of laboratory and instrumental indicators in patients with acute coronary syndrome (ACS) with ST-segment elevation at the hospital stage of treatment.
Materials and methods. 120 patients with ACS with ST segment elevation were examined. The criteria for inclusion in the study were the presence of acute coronary syndrome with ST segment elevation and the presence of at least one lesion of the non infarct-related (non-IRA) coronary artery with stenosis of 70 % or more according to coronary angiography. Exclusion criteria were severe clinical condition of the patient (ischemic time of more than 24 hours, cardiogenic shock, clinical death at the pre-hospital stage, presence of mechanical complications of myocardial infarction), coronary artery bypass grafting, unsuitable for PCI coronary anatomy, etc. All patients were divided into a group of complete (n=60) and a group of incomplete (n=60) revascularization. The complete revascularization group included patients who received stenting of all hemodynamically significant stenoses of the coronary arteries either during primary PCI (subgroup of immediate non-IRA stenting, n=7) or during a separate planned PCI procedure (subgroup of staged stenting non-IRA, n=53).
Results and discussion. According to the echocardiography before discharge from the hospital, patients who underwent a complete procedure (both one-time and staged) had a significantly higher left ventricular ejection fraction compared to patients in the incomplete revascularization group (46.3±6.41 % vs. 43.2±8.32 %, p=0.03). The anatomical complexity of the infarct-related lesion according to the SYNTAX score had a positive correlation with the duration of the primary PCI (correlation coefficient r=0.2; p<0.05) and a decrease in the left ventricular ejection fraction before discharge from the hospital (r=–0.26, p<0.05). An increase in the duration of PCI was associated with an increase in leukocyte count and creatinine levels in the first 48-72 hours after the intervention. However, there was no significant difference in the incidence of contrast-induced nephropathy. A positive correlation was found between the level of LDL and the deterioration of kidney function after pPCI (r=0.27, p<0.05), as well as the degree of non-IRA stenosis (3.39±0.99 mmol/l in patients with with non-IRA stenoses > 90 % versus 2.77±0.68 mmol/l in patients with non-IRA stenoses 70-89 %, p<0.05). While the complexity of non-IRA lesions according to the SYNTAX score had a negative correlation with the level of LDL (r=–0.26, p<0.05).
Conclusions. Complete revascularization in ACS with ST-elevation patients was associated with higher LVEF before hospital discharge. Immediate stenting of all non-IRA during pPCI is associated with increased procedure time but has a lower total radiation burden compared with a staged PCI strategy. The complexity of the infarct-related lesion according to the SYNTAX score is an unmodified predictor of the duration of the pPCI and the reduction of LVEF in the short observation period. Increasing the duration of pPCI leads to a more pronounced inflammatory response with an increase in the level of leukocyte count and an increase of creatinine in the first 48-72 hours after pPCI. LDL is a risk factor for the deterioration of renal function after PCI and the presence of > 90 % non-IRA lesions. However, these lesions have less anatomical complexity.

Article Details

Keywords:

acute coronary syndrome, acute myocardial infarction, complete revascularization, percutaneous coronary intervention, contrast-induced nephropathy

References

Уніфікований клінічний протокол екстреної, первинної, вторинної (спеціалізованої), третинної (високо­­­спеціалізованої) медичної допомоги та кардіореабілітації «Гострий коронарний синдром з елевацією сегмента ST» Наказ МОЗ України №1936 (14.09.2021).

Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimský P; ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC), Eur Heart J. 2018 Jan 7;39(2):119-77. https://doi.org/10.1093/eurheartj/ehx393.

Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, Claeys MJ, Dan GA, Dweck MR, Galbraith M, Gilard M, Hinterbuchner L, Jankowska EA, Jüni P, Kimura T, Kunadian V, Leosdottir M, Lorusso R, Pedretti RFE, Rigopoulos AG, Rubini Gimenez M, Thiele H, Vranckx P, Wassmann S, Wenger NK, Ibanez B; ESC Scientific Document Group. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023 Oct 12;44(38):3720-826. https://doi.org/10.1093/eurheartj/ehad191. Erratum in: Eur Heart J. 2024 Feb 22; PMID: 37622654.

Chan MY, Sun JL, Newby LK, Shaw LK, Lin M, Peterson ED, Califf RM, Kong DF, Roe MT. Long-term mortality of patients undergoing cardiac catheterization for ST-elevation and non-ST-elevation myocardial infarction. Circulation. 2009 Jun 23;119(24):3110-7. https://doi.org/10.1161/CIRCULATIONAHA.108.799981. Epub 2009 Jun 8. Erratum in: Circulation. 2009 Jul 28;120(4):e28. PMID: 19506116.

Diletti R, den Dekker WK, Bennett J, Schotborgh CE, van der Schaaf R, Sabaté M, Moreno R, Ameloot K, van Bommel R, Forlani D, van Reet B, Esposito G, Dirksen MT, Ruifrok WPT, Everaert BRC, Van Mieghem C, Elscot JJ, Cummins P, Lenzen M, Brugaletta S, Boersma E, Van Mieghem NM; BIOVASC Investigators. Immediate versus staged complete revascularisation in patients presenting with acute coronary syndrome and multivessel coronary disease (BIOVASC): a prospective, open-label, non-inferiority, randomised trial. Lancet. 2023 Apr 8;401(10383):1172-1182. https://doi.org/10.1016/S0140-6736(23)00351-3. Epub 2023 Mar 5. PMID: 36889333.

Ferrari JP, Lueneberg ME, da Silva RL, Fattah T, Gottschall CAM, Moreira DM. Correlation between leukocyte count and infarct size in ST segment elevation myocardial infarction. Arch Med Sci Atheroscler Dis. 2016 Jun 21;1(1):e44-e48. https://doi.org/10.5114/amsad.2016.60759. PMID: 28905018; PMCID: PMC5421522.

Gersh BJ, Stone GW, White HD, Holmes DR Jr. Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future? JAMA. 2005 Feb 23;293(8):979-86. https://doi.org/10.1001/jama.293.8.979.

Harari E, Eisen A. Early treatment with high-potency statins in patients with acute coronary syndrome-an example of personalized medicine. J Thorac Dis. 2018 Jun;10(Suppl 17):S2062-S2066. https://doi.org/10.21037/jtd.2018.05.185. PMID: 30023119; PMCID: PMC6036014.

Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, Crews DC, Doria A, Estrella MM, Froissart M, Grams ME, Greene T, Grubb A, Gudnason V, Gutiérrez OM, Kalil R, Karger AB, Mauer M, Navis G, Nelson RG, Poggio ED, Rodby R, Rossing P, Rule AD, Selvin E, Seegmiller JC, Shlipak MG, Torres VE, Yang W, Ballew SH, Couture SJ, Powe NR, Levey AS; Chronic Kidney Disease Epidemiology Collaboration. New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race. N Engl J Med. 2021 Nov 4;385(19):1737-49. https://doi.org/10.1056/NEJMoa2102953. Epub 2021 Sep 23. PMID: 34554658; PMCID: PMC8822996.

Katamine M, Minami Y, Hashimoto T, Ako J. Familial hypercholesterolemia and vulnerability of coronary plaque in patients with coronary artery disease. Pract Lab Med. 2021 Jan 19;24:e00202. https://doi.org/10.1016/j.plabm.2021.e00202. PMID: 33659602; PMCID: PMC7895842.

Liu YH, Liu Y, Chen JY, Zhou YL, Chen ZJ, Yu DQ, Luo JF, Li HL, He YT, Ye P, Ran P, Guo W, Tan N. LDL cholesterol as a novel risk factor for contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention. Atherosclerosis. 2014 Dec;237(2):453-9. https://doi.org/10.1016/j.atherosclerosis.2014.10.022. Epub 2014 Oct 17. PMID: 25463073.

Mehta SR, Wood DA, Storey RF, Mehran R, Bainey KR, Nguyen H, Meeks B, Di Pasquale G, López-Sendón J, Faxon DP, Mauri L, Rao SV, Feldman L, Steg PG, Avezum Á, Sheth T, Pinilla-Echeverri N, Moreno R, Campo G, Wrigley B, Kedev S, Sutton A, Oliver R, Rodés-Cabau J, Stanković G, Welsh R, Lavi S, Cantor WJ, Wang J, Nakamya J, Bangdiwala SI, Cairns JA; COMPLETE Trial Steering Committee and Investigators. Complete Revascularization with Multivessel PCI for Myocardial Infarction. N Engl J Med. 2019 Oct 10;381(15):1411-21. https://doi.org/10.1056/NEJMoa1907775. Epub 2019 Sep 1. PMID: 31475795.

Núñez J, Fácila L, Llàcer A, Sanchís J, Bodí V, Bertomeu V, Sanjuán R, Blasco ML, Consuegra L, Bosch MJ, Chorro FJ. Valor pronóstico del recuento leucocitario en el infarto agudo de miocardio: mortalidad a largo plazo [Prognostic value of white blood cell count in acute myocardial infarction: long-term mortality]. Rev Esp Cardiol. 2005 Jun;58(6):631-9. https://doi.org/10.1157/13076415. Spanish. PMID: 15970118.

Núñez J, Núñez E, Sanchis J, Bodí V, Llàcer A. Prognostic value of leukocytosis in acute coronary syndromes: the cinderella of the inflammatory markers. Curr Med Chem. 2006;13(18):2113-8. https://doi.org/10.2174/092986706777935221. PMID: 16918341.

Puymirat E, Simon T, Cayla G, Cottin Y, Elbaz M, Coste P, Lemesle G, Motreff P, Popovic B, Khalife K, Labèque JN, Perret T, Le Ray C, Orion L, Jouve B, Blanchard D, Peycher P, Silvain J, Steg PG, Goldstein P, Guéret P, Belle L, Aissaoui N, Ferrières J, Schiele F, Danchin N. Acute Myocardial Infarction: Changes in Patient Characteristics, Management, and 6-Month Outcomes Over a Period of 20 Years in the FAST-MI Program (French Registry of Acute ST-Elevation or Non-ST-Elevation Myocardial Infarction) 1995 to 2015. Circulation. 2017 Nov 14;136(20):1908-19. https://doi.org/10.1161/CIRCULATIONAHA.117.030798. Epub 2017 Aug 27. PMID: 28844989.

Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, Ståhle E, Feldman TE, van den Brand M, Bass EJ, Van Dyck N, Leadley K, Dawkins KD, Mohr FW; SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009 Mar 5;360(10):961-72. https://doi.org/10.1056/NEJMoa0804626. Epub 2009 Feb 18. Erratum in: N Engl J Med. 2013 Feb 7;368(6):584. PMID: 19228612.

Sheth T, Pinilla-Echeverri N, Moreno R, Wang J, Wood DA, Storey RF, Mehran R, Bainey KR, Bossard M, Bangalore S, Schwalm JD, Velianou JL, Valettas N, Sibbald M, Rodés-Cabau J, Ducas J, Cohen EA, Bagai A, Rinfret S, Newby DE, Feldman L, Laster SB, Lang IM, Mills JD, Cairns JA, Mehta SR. Nonculprit Lesion Severity and Outcome of Revascularization in Patients With STEMI and Multivessel Coronary Disease. J Am Coll Cardiol. 2020 Sep, 76 (11) 1277–1286. https://doi.org/10.1016/j.jacc.2020.07.034

Smits PC, Laforgia PL, Abdel-Wahab M, Neumann FJ, Richardt G, Boxma-de Klerk B, Lunde K, Schotborgh CE, Piroth Z, Horak D, Wlodarczak A, Frederix GW, Omerovic E. Fractional flow reserve-guided multivessel angioplasty in myocardial infarction: three-year follow-up with cost benefit analysis of the Compare-Acute trial. EuroIntervention. 2020 Jun 25;16(3):225-32. https://doi.org/10.4244/EIJ-D-20-00012. PMID: 32250250.

Stähli BE, Varbella F, Linke A, Schwarz B, Felix SB, Seiffert M, Kesterke R, Nordbeck P, Witzenbichler B, Lang IM, Kessler M, Valina C, Dibra A, Rohla M, Moccetti M, Vercellino M, Gaede L, Bott-Flügel L, Jakob P, Stehli J, Candreva A, Templin C, Schindler M, Wischnewsky M, Zanda G, Quadri G, Mangner N, Toma A, Magnani G, Clemmensen P, Lüscher TF, Münzel T, Schulze PC, Laugwitz KL, Rottbauer W, Huber K, Neumann FJ, Schneider S, Weidinger F, Achenbach S, Richardt G, Kastrati A, Ford I, Maier W, Ruschitzka F; MULTISTARS AMI Investigators. Timing of Complete Revascularization with Multivessel PCI for Myocardial Infarction. N Engl J Med. 2023 Oct 12;389(15):1368-79. https://doi.org/10.1056/NEJMoa2307823. Epub 2023 Aug 27. PMID: 37634190.

Torguson R, Mintz GS, Zhang C, Case BC, Di Mario C, Garcia-Garcia HM, Waksman R. Lipid-rich plaque density and low-density lipoprotein cholesterol in statin-treated versus statin-naïve patients: a post hoc analysis of the LRP study. EuroIntervention. 2022 May 15;18(1):91-3. https://doi.org/10.4244/EIJ-D-21-00701. PMID: 35037626; PMCID: PMC9903151.

Tripathi B, Yeh RW, Bavishi CP, Sardar P, Atti V, Mukherjee D, Bashir R, Abbott JD, Giri J, Chatterjee S. Etiologies, Trends, and Predictors of Readmission in ST-Elevation Myocardial Infarction Patients Undergoing Multivessel Percutaneous Coronary Intervention. Catheter. Cardiovasc. Interv. 2019;94:905-14. https://doi.org/10.1002/ccd.28344.

Valenti R, Migliorini A, Signorini U, Vergara R, Parodi G, Carrabba N, Cerisano G, Antoniucci D. Impact of complete revascularization with percutaneous coronary intervention on survival in patients with at least one chronic total occlusion. Eur Heart J. 2008 Oct;29(19):2336-42. https://doi.org/10.1093/eurheartj/ehn357. Epub 2008 Aug 5. PMID: 18682446. https://doi.org/10.1093/eurheartj/ehn357.

Most read articles by the same author(s)

1 2 > >>